-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Palvella Therapeutics, Raises Price Target to $133

Benzinga·12/16/2025 14:06:32
Listen to the news
TD Cowen analyst Ritu Baral maintains Palvella Therapeutics (NASDAQ:PVLA) with a Buy and raises the price target from $97 to $133.